FTIDC   Click here for help

GtoPdb Ligand ID: 6363

Compound class: Synthetic organic
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 6
Hydrogen bond donors 0
Rotatable bonds 5
Topological polar surface area 66.63
Molecular weight 358.19
XLogP 1.38
No. Lipinski's rules broken 0
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES CC(N(C(=O)N1CCC(=CC1)c1nnn(c1C)c1cccnc1F)C)C
Isomeric SMILES CC(N(C(=O)N1CCC(=CC1)c1nnn(c1C)c1cccnc1F)C)C
InChI InChI=1S/C18H23FN6O/c1-12(2)23(4)18(26)24-10-7-14(8-11-24)16-13(3)25(22-21-16)15-6-5-9-20-17(15)19/h5-7,9,12H,8,10-11H2,1-4H3
InChI Key CJTLKLBSIFQKNT-UHFFFAOYSA-N
References
1. Suzuki G, Kimura T, Satow A, Kaneko N, Fukuda J, Hikichi H, Sakai N, Maehara S, Kawagoe-Takaki H, Hata M et al.. (2007)
Pharmacological characterization of a new, orally active and potent allosteric metabotropic glutamate receptor 1 antagonist, 4-[1-(2-fluoropyridin-3-yl)-5-methyl-1H-1,2,3-triazol-4-yl]-N-isopropyl-N-methyl-3,6-dihydropyridine-1(2H)-carboxamide (FTIDC).
J Pharmacol Exp Ther, 321 (3): 1144-53. [PMID:17360958]